This site is intended for healthcare professionals only
LoginRegister
Azithromycin, Ofloxacin Combos Among 3 Drug Batches Flagged as Purportedly Spurious by CDSCOCDSCO Flags Ursodeoxycholic Acid Tablets Batch as Purportedly Spurious
Aurobindo Pharma FY26 Revenue Tops Rs 33,600 Cr, Europe Sales Surge 30%Aurobindo Pharma FY26 Revenue Tops Rs 33,600 Cr, Europe Sales Surge 30%
Sun Pharma Q4 Profit Jumps 26% to Rs 2,714 Cr, India Sales Drive Strong FY26 GrowthSun Pharma Q4 Profit Jumps 26% to Rs 2,714 Cr, India Sales Drive Strong FY26 Growth
AstraZeneca Gets EMA Panel Nod for Camizestrant Breast Cancer Pill After USFDA SetbackAstraZeneca Gets EMA Panel Nod for Camizestrant Breast Cancer Pill After USFDA Setback
Lupin Gets China NMPA Nod for Oseltamivir Suspension, Marks Entry into Chinese MarketLupin Gets China NMPA Nod for Oseltamivir Suspension, Marks Entry into Chinese Market
42 Drug Batches Including Paracetamol, Metformin Fail CDSCO Quality Tests in April42 Drug Batches Including Paracetamol, Metformin Fail CDSCO Quality Tests in April
Akums Subsidiaries Receive Rs 22 Crore Income Tax Demands Over Expense DisallowancesAkums Subsidiaries Receive Rs 22 Crore Income Tax Demands Over Expense Disallowances
Jubilant Pharmova Q4 Profit Slips 21% to Rs 119 Cr Despite Revenue GrowthJubilant Pharmova Q4 Profit Slips 21% to Rs 119 Cr Despite Revenue Growth
Novo Nordisk Nears Europe Launch of Oral Wegovy After EMA RecommendationNovo Nordisk Nears Europe Launch of Oral Wegovy After EMA Recommendation
Pregabalin to Be Sold Only Under Tighter Prescription Monitoring: Health MinistryPregabalin to Be Sold Only Under Tighter Prescription Monitoring: Health Ministry
Alembic Pharma Secures USFDA Approval for Generic Synthroid TabletsAlembic Pharma Secures USFDA Approval for Generic Synthroid Tablets
CDSCO Approves Astellas PADCEV-Pembrolizumab Combo for Advanced Bladder CancerCDSCO Approves Astellas' PADCEV-Pembrolizumab Combo for Advanced Bladder Cancer
X